Plans will need to be prepared to manage this drug as we can expect tremendous growth, especially due to off-label utilization and shortages of Wegovy and Ozempic
Its there because no one has given you a plan that actually works with your biology
At your first virtual visit, youll meet with a local and experienced provider to review your medical history and weight loss goals
Most GLP-1 side effects are gastrointestinal, mild, and improve within the first few weeks of each dose level Serious warning signs severe abdominal pain, persistent vomiting, or allergic reactions are rare but require immediate medical attention Wegovy, Zepbound, and Foundayo share a similar GI side-effect profile, with some differences in nausea and diarrhea frequency In-person monitoring at PEAK allows your clinician to catch issues early and adjust your titration schedule in real time Starting a GLP-1 medication like Wegovy (semaglutide), Zepbound (tirzepatide), or Foundayo (orforglipron) is a major step toward better health and it is completely normal to wonder what to expect along the way
Why the Dual Targeting Matters While GLP-1 receptor agonists like semaglutide are already successful in treating type 2 diabetes, combining it with GIP signaling unlocks greater benefits